Melinda Hsu, MD
- Specialty: Hematology and Oncology, Medical Oncology
-
Primary Location: 2075 Healthway Dr (22 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Seidman Avon Health Center (22 mi.)
2075 Healthway Dr
2nd Floor
Avon, OH 44011
440-517-9000
UH Seidman Cancer Center (0 mi.)
11100 Euclid Ave
1st Floor
Cleveland, OH 44106
216-844-3951
UH Seidman Minoff Health Center (7 mi.)
3909 Orange Pl
Ste 1100
Beachwood, OH 44122
216-896-1750
Biography: Melinda Hsu, MD
Titles
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Medical Oncology
Medical Oncology - Johns Hopkins Hospital (2018 - 2021)
Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - Indiana University Hospital (2017 - 2018)
Residency | Internal Medicine
Internal Medicine - Indiana University Hospital (2014 - 2017)
Medical Education
University Of Cincinnati College Of Medicine (2014)
Other Education
Georgetown University (2006)
Undergraduate
Harvard University (2005)
Featured Videos
Watch to find out more about this University Hospitals provider.
Patient Experience Reviews
I am very happy being a new patient of Dr.Hsu.She is very caring and makes you feel she will do everything possible to help.
Love and respect this doctor and her team!
All good!
*** Dr Hsu has been nothing but very informative, concerned, compassionate, empathetic, and genuinely concerned about me
No Bad Experience.
It was very good
Dr. Hsu is exceptional in assessing my current health status and the effects of medications on my health status. Involves me and my husband in the plan of care. Excellent patient/ family interaction and concern for my safety.
Dr. Hsu made me feel like I was the only patient she had for the day. I was not rushed and was given all the time I needed with the doctor. I was treated with kindness and respect.
Dr Hsu was extremely helpful and informative.
Very professional
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Melinda Hsu did not disclose any Outside Relationships with Industry.